Counseling + Biospecimen Collection + Interview + Survey Administration + Psilocybin for depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Oct 2025: Trial registered, NCT07216404
  2. 1 Jan 2026: Trial started, NCT07216404

The trials

NCT07216404: Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

State
Under way
Phase
Phase 2
People
10 planned
Started
1 Jan 2026
Primary completion
31 Oct 2027
Arms
Supportive Care (counseling sessions, psilocybin)
Results
None posted
  1. 14 Oct 2025: Trial registered
  2. 1 Jan 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.